Temporal regulation of mRNAs for select bone morphogenetic proteins (BMP), BMP receptors and their associated SMAD proteins during bovine early embryonic development: effects of exogenous BMP2 on embryo developmental progression

Reproductive Biology and Endocrinology

George W Smith¹  Sandeep K Rajput³  Joseph K Folger³  Kyung-Bon Lee² 

[1] Department of Physiology, Michigan State University, East Lansing, MI 48824, USA;Department of Biology Education, College of Education, Chonnam National University, Gwangju 500-757, Republic of Korea;Department of Animal Science, Michigan State University, East Lansing, MI 48824, USA

关键词: SMAD;    BMP receptor;    BMP;    Blastocyst;    Embryo;    Oocyte;    Bovine;    Ovary;   

Others  :  1139788
DOI  :  10.1186/1477-7827-12-67

 received in 2014-02-25, accepted in 2014-07-07,  发布年份 2014

【 摘 要 】

Background

We previously demonstrated embryotrophic actions of maternal (oocyte-derived) follistatin during bovine early embryogenesis. Classical actions of follistatin are attributed to inhibition of activity of growth factors including activins and bone morphogenetic proteins (BMP). However, temporal changes in BMP mRNA in early bovine embryos and the effects of exogenous BMP on embryo developmental progression are not understood. The objectives of present studies were to characterize mRNA abundance for select BMP, BMP receptors and BMP receptor associated SMADs during bovine oocyte maturation and early embryogenesis and determine effects of addition of exogenous BMP protein on early development.

Methods

Relative abundance of mRNA for BMP2, BMP3, BMP7, BMP10, SMAD1, SMAD5, ALK3, ALK6, ALK2, BMPR2, ACVR2A and ACVR2B was determined by RT-qPCR analysis of germinal vesicle (GV) and in vitro matured metaphase II (MII) oocytes and in vitro produced embryos collected at pronuclear, 2-cell (C), 4C, 8C, 16C, morula and blastocyst stages. Effects of addition of recombinant human BMP2 (0, 1, 10 and 100 ng/ml) during initial 72 h of embryo culture on early cleavage (within 30 h post insemination), total cleavage, development to 8C-16C and blastocyst stages and blastocyst mRNA abundance for markers of inner cell mass (NANOG) and trophectoderm (CDX2) were also determined.

Results

Abundance of mRNA for BMP2, BMP10, SMAD1, SMAD5, ALK3, ALK2, BMPR2 and ACVR2B was elevated in MII oocytes and/or pronuclear stage embryos (relative to GV) and remained elevated through the 8C -16C stages, whereas BMP3, BMP7 and ALK2 mRNAs were transiently elevated. Culture of embryos to the 8C stage in the presence of α-amanitin resulted in increased abundance for all of above transcripts examined relative to untreated 8C embryos. Effects of addition of exogenous BMP2 on early cleavage rates and rates of development to 8C-16C and blastocyst stages were not observed, but BMP2 treatment increased blastocyst mRNA for CDX2 and NANOG.

Conclusions

Abundance of maternally derived mRNAs for above BMP system components are dynamically regulated during oocyte maturation and early embryogenesis. Exogenous BMP2 treatment does not influence progression to various developmental endpoints, but impacts characteristics of resulting blastocysts. Results support a potential role for BMPs in bovine early embryogenesis.

【 授权许可】

   
2014 Lee et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Sirard MA, Richard F, Blondin P, Robert C: Contribution of the oocyte to embryo quality. Theriogenology 2006, 65:126-136.
• [2]Patel OV, Bettegowda A, Ireland JJ, Coussens PM, Lonergan P, Smith GW: Functional genomics studies of oocyte competence: evidence that reduced transcript abundance for follistatin is associated with poor developmental competence of bovine oocytes. Reproduction 2007, 133:95-106.
• [3]Lee KB, Bettegowda A, Wee G, Ireland JJ, Smith GW: Molecular determinants of oocyte competence: potential functional role for maternal (oocyte-derived) follistatin in promoting bovine early embryogenesis. Endocrinology 2009, 150:2463-2471.
• [4]VandeVoort CA, Mtango NR, Lee YS, Smith GW, Latham KE: Differential effects of follistatin on nonhuman primate oocyte maturation and pre-implantation embryo development in vitro. Biol Reprod 2009, 81:1139-1146.
• [5]Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H: Activin-binding protein from rat ovary is follistatin. Science 1990, 247:836-838.
• [6]Balemans W, Van Hul W: Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 2002, 250:231-250.
• [7]Lin SY, Morrison JR, Phillips DJ, de Kretser DM: Regulation of ovarian function by the TGF-beta superfamily and follistatin. Reproduction 2003, 126:133-148.
• [8]Otsuka F, Moore RK, Iemura S, Ueno N, Shimasaki S: Follistatin inhibits the function of the oocyte-derived factor BMP-15. Biochem Biophys Res Commun 2001, 289:961-966.
• [9]Kimelman D, Pyati UJ: Bmp signaling: turning a half into a whole. Cell 2005, 123:982-984.
• [10]Giakoumopoulos M, Golos TG: Embryonic stem cell-derived trophoblast differentiation: a comparative review of the biology, function, and signaling mechanisms. J Endocrinol 2013, 216:R33-R45.
• [11]Bettegowda A, Patel OV, Ireland JJ, Smith GW: Quantitative analysis of messenger RNA abundance for ribosomal protein L-15, cyclophilin-A, phosphoglycerokinase, beta-glucuronidase, glyceraldehyde 3-phosphate dehydrogenase, beta-actin, and histone H2A during bovine oocyte maturation and early embryogenesis in vitro. Mol Reprod Dev 2006, 73:267-278.
• [12]Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
• [13]Kocabas AM, Crosby J, Ross PJ, Otu HH, Beyhan Z, Can H, Tam WL, Rosa GJ, Halgren RG, Lim B, Fernandez E, Cibelli JB: The transcriptome of human oocytes. Proc Natl Acad Sci U S A 2006, 103:14027-14032.
• [14]Hussein TS, Sutton-McDowall ML, Gilchrist RB, Thompson JG: Temporal effects of exogenous oocyte-secreted factors on bovine oocyte developmental competence during IVM. Reprod Fertil Dev 2011, 23:576-584.
• [15]Hussein TS, Thompson JG, Gilchrist RB: Oocyte-secreted factors enhance oocyte developmental competence. Dev Biol 2006, 296:514-521.
• [16]Cao X, Chen D: The BMP signaling and in vivo bone formation. Gene 2005, 357:1-8.
• [17]Glister C, Kemp CF, Knight PG: Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 2004, 127:239-254.
• [18]Glister C, Satchell L, Knight PG: Changes in expression of bone morphogenetic proteins (BMPs), their receptors and inhibin co-receptor betaglycan during bovine antral follicle development: inhibin can antagonize the suppressive effect of BMPs on thecal androgen production. Reproduction 2010, 140:699-712.
• [19]Fatehi AN, van den Hurk R, Colenbrander B, Daemen AJ, van Tol HT, Monteiro RM, Roelen BA, Bevers MM: Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development. Theriogenology 2005, 63:872-889.
• [20]Bettegowda A, Smith GW: Mechanisms of maternal mRNA regulation: implications for mammalian early embryonic development. Front Biosci 2007, 12:3713-3726.
• [21]Bettegowda A, Lee KB, Smith GW: Cytoplasmic and nuclear determinants of the maternal-to-embryonic transition. Reprod Fertil Dev 2008, 20:45-53.
• [22]Guhaniyogi J, Brewer G: Regulation of mRNA stability in mammalian cells. Gene 2001, 265:11-23.
• [23]Lee KB, Wee G, Zhang K, Folger JK, Knott JG, Smith GW: Functional Role of the Bovine Oocyte-Specific Protein JY-1 in Meiotic Maturation, Cumulus Expansion, and Subsequent Embryonic Development. Biol Reprod 2014., 90(3) Article 69 (1-7)
• [24]Barros R, Pereira B, Duluc I, Azevedo M, Mendes N, Camilo V, Jacobs RJ, Paulo P, Santos-Silva F, van Seuningen I, van den Brink GR, David L, Freund JN, Almeida R: Key elements of the BMP/SMAD pathway co-localize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines. J Pathol 2008, 215:411-420.
• [25]Hayashi Y, Furue MK, Tanaka S, Hirose M, Wakisaka N, Danno H, Ohnuma K, Oeda S, Aihara Y, Shiota K, Ogura A, Ishiura S, Asashima M: BMP4 induction of trophoblast from mouse embryonic stem cells in defined culture conditions on laminin. In Vitro Cell Dev Biol Anim 2010, 46:416-430.
• [26]Wu Z, Zhang W, Chen G, Cheng L, Liao J, Jia N, Gao Y, Dai H, Yuan J, Xiao L: Combinatorial signals of activin/nodal and bone morphogenic protein regulate the early lineage segregation of human embryonic stem cells. J Biol Chem 2008, 283:24991-25002.
• [27]Silva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, Barrandon O, Wray J, Yamanaka S, Chambers I, Smith A: Nanog is the gateway to the pluripotent ground state. Cell 2009, 138:722-737.
• [28]Berg DK, Smith CS, Pearton DJ, Wells DN, Broadhurst R, Donnison M, Pfeffer PL: Trophectoderm lineage determination in cattle. Dev Cell 2011, 20:244-255.
• [29]Deb K, Sivaguru M, Yong HY, Roberts RM: Cdx2 gene expression and trophectoderm lineage specification in mouse embryos. Science 2006, 311:992-996.
• [30]Chen L, Yabuuchi A, Eminli S, Takeuchi A, Lu CW, Hochedlinger K, Daley GQ: Cross-regulation of the Nanog and Cdx2 promoters. Cell Res 2009, 19:1052-1061.